Open Market Insiders Trades - Buys only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 100 Added 1.09% |
$19,575
$195.75 p/Share
|
Jul 07
2010 |
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 25 Added 0.01% |
$4,610
$184.39 p/Share
|
Jul 07
2010 |
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 175 Added 1.91% |
$34,562
$197.5 p/Share
|
Jul 01
2010 |
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 300 Added 12.9% |
$60,426
$201.42 p/Share
|
Jun 24
2010 |
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 150 Added 8.0% |
$31,200
$208.0 p/Share
|
Jun 23
2010 |
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 50 Added 0.01% |
$10,625
$212.5 p/Share
|
Jun 21
2010 |
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 25 Added 0.0% |
$5,125
$205.0 p/Share
|
Jun 17
2010 |
CHRD
|
Thomas B Nusz
CEO |
BUY
Open market or private purchase
|
Indirect | 5,700 Added 50.0% |
$79,800
$14.0 p/Share
|
Jun 17
2010 |
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 200 Added 0.02% |
$40,650
$203.25 p/Share
|
Jun 16
2010 |
IDIX
|
Ag Novartis |
BUY
Open market or private purchase
|
Indirect | 1,351 Added 0.0% |
$3,256
$2.41 p/Share
|
Jun 08
2010 |
IOGPQ
|
James M Lapeyre Jr
Director |
BUY
Open market or private purchase
|
Direct | 40,000 Added 2.39% |
$179,600
$4.49 p/Share
|
Jun 07
2010 |
IOGPQ
|
James M Lapeyre Jr
Director |
BUY
Open market or private purchase
|
Indirect | 60,000 Added 9.92% |
$284,400
$4.74 p/Share
|
Jun 07
2010 |
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 125 Added 7.81% |
$24,999
$199.99 p/Share
|
May 28
2010 |
FCNCA
|
Holding Frank B Jr
Chairman and CEO |
BUY
Open market or private purchase
|
Indirect | 300 Added 1.53% |
$58,500
$195.0 p/Share
|
May 26
2010 |
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 300 Added 0.05% |
$58,500
$195.0 p/Share
|
May 26
2010 |
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 12 Added 0.0% |
$2,286
$190.5 p/Share
|
May 25
2010 |
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 150 Added 10.0% |
$29,250
$195.0 p/Share
|
May 21
2010 |
IOGPQ
|
James M Lapeyre Jr
Director |
BUY
Open market or private purchase
|
Direct | 25,000 Added 1.54% |
$127,750
$5.11 p/Share
|
May 21
2010 |
IOGPQ
|
James M Lapeyre Jr
Director |
BUY
Open market or private purchase
|
Indirect | 75,000 Added 13.39% |
$381,750
$5.09 p/Share
|
May 21
2010 |
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 775 Added 39.24% |
$155,961
$201.24 p/Share
|
May 20
2010 |
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 300 Added 3.29% |
$62,049
$206.83 p/Share
|
May 18
2010 |
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 60 Added 6.64% |
$12,330
$205.5 p/Share
|
May 18
2010 |
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 75 Added 15.0% |
$15,525
$207.0 p/Share
|
May 13
2010 |
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 25 Added 6.67% |
$5,125
$205.0 p/Share
|
May 11
2010 |
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 262 Added 7.97% |
$53,252
$203.25 p/Share
|
May 10
2010 |
MEI
|
Timothy Glandon
Vice President |
BUY
Open market or private purchase
|
Direct | 21 Added 0.59% |
$236
$11.22 p/Share
|
Apr 30
2010 |
ALNY
|
Ag Novartis
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 55,223 Added 0.98% |
$993,462
$17.99 p/Share
|
Apr 23
2010 |
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 130 Added 3.28% |
$26,780
$206.0 p/Share
|
Apr 09
2010 |
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 50 Added 0.01% |
$10,158
$203.16 p/Share
|
Apr 09
2010 |
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 200 Added 2.3% |
$41,030
$205.15 p/Share
|
Apr 08
2010 |
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 200 Added 38.1% |
$40,160
$200.8 p/Share
|
Apr 05
2010 |
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 125 Added 50.0% |
$25,142
$201.14 p/Share
|
Apr 01
2010 |
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 300 Added 0.03% |
$61,680
$205.6 p/Share
|
Mar 30
2010 |
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 231 Added 6.16% |
$47,240
$204.5 p/Share
|
Mar 25
2010 |
SPOK
|
Tom Saine
Chief Information Officer |
BUY
Open market or private purchase
|
Direct | 395 Added 1.43% |
$4,922
$12.46 p/Share
|
Mar 22
2010 |
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 30 Added 2.73% |
$6,255
$208.5 p/Share
|
Mar 18
2010 |
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 25 Added 50.0% |
$4,978
$199.1 p/Share
|
Mar 12
2010 |
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 600 Added 20.0% |
$118,800
$198.0 p/Share
|
Mar 11
2010 |
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 300 Added 14.29% |
$60,300
$201.0 p/Share
|
Mar 09
2010 |
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 350 Added 9.62% |
$68,775
$196.5 p/Share
|
Mar 08
2010 |
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 10 Added 3.13% |
$1,870
$187.0 p/Share
|
Mar 08
2010 |
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 1,000 Added 40.0% |
$182,000
$182.0 p/Share
|
Mar 04
2010 |
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 200 Added 28.57% |
$36,172
$180.86 p/Share
|
Mar 02
2010 |
IDIX
|
Ag Novartis |
BUY
Open market or private purchase
|
Indirect | 1,872 Added 0.01% |
$4,512
$2.41 p/Share
|
Feb 26
2010 |
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 150 Added 33.33% |
$26,850
$179.0 p/Share
|
Feb 24
2010 |
IOGPQ
|
James M Lapeyre Jr
Director |
BUY
Open market or private purchase
|
Direct | 50,000 Added 3.09% |
$218,000
$4.36 p/Share
|
Feb 24
2010 |
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 150 Added 50.0% |
$27,300
$182.0 p/Share
|
Feb 23
2010 |
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 193 Added 1.68% |
$34,161
$177.0 p/Share
|
Feb 22
2010 |
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 604 Added 36.78% |
$105,313
$174.36 p/Share
|
Feb 16
2010 |
CHTT
|
Sanofi
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 923,268 Added 1.95% |
$86,325,558
$93.5 p/Share
|
Feb 11
2010 |